ResearcherNankai UniversityNo recent work listed

Hui Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3816-3182; OpenAlex author ID A5100460937. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper

Papers 2

Bibliometric Analysis of Hotspots and Frontiers of Immunotherapy in Pancreatic Cancer. Last author DOI 10.3390/healthcare11030304 ↗
A prognostic nomogram for pancreatic ductal adenocarcinoma patients' all-cause survival in a Surveillance, Epidemiology, and End Results analysis. Co-author DOI 10.21037/tcr-19-2962 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Haipeng Li · 1 shared paper, 2023 · strength 0.22
- Paper Bibliometric Analysis of Hotspots and Frontiers of Immunotherapy in Pancreatic Cancer. DOI 10.3390/healthcare11030304 ↗
Qiong Xu · 1 shared paper, 2023 · strength 0.22
- Paper Bibliometric Analysis of Hotspots and Frontiers of Immunotherapy in Pancreatic Cancer. DOI 10.3390/healthcare11030304 ↗
Chengzhuo Li · 1 shared paper, 2020 · strength 0.13
- Paper A prognostic nomogram for pancreatic ductal adenocarcinoma patients' all-cause survival in a Surveillance, Epidemiology… DOI 10.21037/tcr-19-2962 ↗
Jun Lyu · 1 shared paper, 2020 · strength 0.13
- Paper A prognostic nomogram for pancreatic ductal adenocarcinoma patients' all-cause survival in a Surveillance, Epidemiology… DOI 10.21037/tcr-19-2962 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.